跳至主要内容
临床试验/NCT04829357
NCT04829357招募中不适用

A Long Term Prospective Post Market Clinical Follow-up (PMCF) of the GYNECARE TVT ABBREVO® Continence System for the Treatment of Stress Urinary Incontinence

Ethicon, Inc.4 个研究点 分布在 3 个国家目标入组 195 人开始时间: 2021年9月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Ethicon, Inc.
入组人数
195
试验地点
4
主要终点
Cough Stress Test (CST) Assessment Change

研究概览

简要总结

The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT ABBREVO® Continence System in women undergoing Mid-urethral sling surgery for Stress Urinary Incontinence (SUI).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Subjects who satisfy all of the following criteria will be considered eligible for enrollment in this study:
  • Stress urinary incontinence symptoms
  • Diagnostic evaluation, a positive cough stress rest, to confirm diagnosis of stress urinary incontinence.
  • Female subjects ≥ 21 years of age requiring treatment of SUI
  • Desired surgical correction of stress urinary incontinence using synthetic sub-urethral vaginal slings
  • Planned surgery for primary stress incontinence without concomitant prolapse surgery
  • Patient able and willing to participate in follow-up
  • Subject or authorized representative has signed the approved informed consent

排除标准

  • Subjects meeting any of the following criteria will be considered not eligible for enrollment in this study:
  • Physical or psychological condition which would impair study participation or are unwilling or unable to participate in all required study visits and are unable to complete the questionnaires
  • Any pre-operative or intra-operative findings identified by the surgeon that may preclude the use of study product
  • History of previous synthetic, biologic or fascial sub-urethral sling
  • Pregnancy or plans for future pregnancy
  • History of bleeding diathesis or current anti-coagulation therapy which cannot be suspended peri-operatively according to site's standard practice.
  • Current genitourinary fistula or urethral diverticulum
  • Reversible cause of incontinence (i.e. drug effect)
  • Contraindication to surgery

结局指标

主要结局

Cough Stress Test (CST) Assessment Change

时间窗: Post-surgery through study completion, approximately 5-10 yrs

Objective cure of Stress Urinary Incontinence (SUI) (treatment success) approximately 5-10 years after surgery, defined as a negative CST

次要结局

  • Wong-Baker FACES® Pain Rating Scale(Post-surgery through study completion, approximately 10 yrs)
  • International Consultation on Incontinence Questionnaire- Urinary Incontinence Short Form (ICIQ-UI SF)(Baseline and post-surgery through study completion, approximately 10 yrs)
  • Patient Global Impression of Improvement (PGI-I)(Post-surgery through study completion, approximately 10 yrs)
  • Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)(Baseline and post-surgery through study completion, approximately 10 yrs)

研究者

发起方
Ethicon, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Post Market Clinical Follow-up Study on TVT ABBREVO®... | 临床试验